Idexx Laboratories (IDXX) Cash from Investing Activities Growth (1y) (2010 - 2026)
Powered by 
Analysis
Idexx Laboratories (IDXX) Cash from Investing Activities Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn | 24.18% |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn | -41.51% |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn | -96.43% |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn | -133.88% |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn | - |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.18% |
| Mar 31, 2026 | -13.29% |
| Dec 31, 2025 | 29.40% |
| Sep 30, 2025 | -63.95% |
| Jun 30, 2025 | -2.19% |
| Mar 31, 2025 | 72.31% |
| Dec 31, 2024 | -30.91% |
| Sep 30, 2024 | 1.69% |
| Jun 30, 2024 | -19.79% |
| Mar 31, 2024 | -170.67% |
| Dec 31, 2023 | 38.18% |
| Sep 30, 2023 | 43.42% |
| Jun 30, 2023 | 50.13% |
| Mar 31, 2023 | 5.56% |
| Dec 31, 2022 | -11.78% |
| Sep 30, 2022 | 0.97% |
| Jun 30, 2022 | 68.46% |
| Mar 31, 2022 | -70.16% |
| Dec 31, 2021 | -180.69% |
| Sep 30, 2021 | -155.28% |